栄養補助食品市場：タイプ（機能性飲料、機能性食品、栄養補助食品）、形態（カプセル・錠剤、液体、粉末、その他）、販売チャネル（ハイパーマーケット/スーパーマーケット、専門店、薬局、オンラインチャネル）別。世界の機会分析および産業予測、2021-2030年

Nutraceuticals Market by Type, (Functional Beverage, Functional Food, and Dietary Supplements), Form (Capsules and Tablets, Liquid, Powder, Others), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacies, and Online Channels): Global Opportunity Analysis and Industry Forecast, 2021–2030

ニュートラシューティカルズとは、食品と表示されながら、医薬品としても活用されている健康食品のことです。食品素材や抽出物から作られるため、バイオシューティカルズとも呼ばれます。栄養補助食品は、病気の... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年1月13日	US$6,169 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	325	英語

サマリー

ニュートラシューティカルズとは、食品と表示されながら、医薬品としても活用されている健康食品のことです。食品素材や抽出物から作られるため、バイオシューティカルズとも呼ばれます。栄養補助食品は、病気の治療や予防、健康維持・増進、慢性疾患の予防、老化防止、身体の構造や機能のサポート、寿命の延長などのためのサプリメントとして使用されています。市場には様々な種類のニュートラシューティカルズ製品があり、様々な用途に使用されています。これらの製品は食品サプリメントまたは添加物とみなされるため、世界中の多くの国で規制されていません。
世界中の消費者は、自分独自の栄養や健康の目標をより積極的に達成できるような、カスタマイズ可能な食品、飲料、食事療法のソリューションを求めています。活動的で健康志向の高い消費者は、炭水化物や不健康な化学物質を多く含む砂糖ベースの飲料に代わる、自然なものを好むようになっています。機能性飲料は、特定の栄養素やサプリメントで構成されており、運動能力や代謝を向上させる。適切な栄養摂取は、運動能力の効果的な向上、コンディショニング、運動後の疲労回復、ケガの早期回復に不可欠な条件である。さらに、糖尿病の管理にも役立ちます。消費者のライフスタイルの変化は、発展途上国における機能性食品の人気上昇に寄与している主要な要因の1つである。アジア太平洋諸国では、一人当たりの所得が急増したことにより、消費者の食習慣が変化している。贅沢なライフスタイルへの憧れと嗜好の高まりが、市場規模や総需要の多様な増加につながっています。
ニュートラシューティカルズ製品の需要は急速に伸びています。この増加の主な理由は、栄養補助食品の消費による健康と幸福の利点に関する意識の高まりにあります。さらに、仕事のプレッシャーによる厳しいライフスタイルの採用やファーストフードの消費量の増加が、消費者の健康維持に役立つサプリメントの検索を促しています。不健康な食品の消費の増加は、高コレステロール、肥満、骨の劣化、心臓関連の病気などの疾病を引き起こしています。多くの消費者は、健康を維持するためにジムやアスレチックセンターを訪問するようなフィットネス活動の増加を報告し、最大の結果を得るために栄養補助食品とこれらの活動を結合している。
多くの消費者は、食品、健康食品、機能性食品、タンパク質、栄養補助食品に含まれる化学成分を避けています。そのため、自然由来の原料やハーブを使用したトマト缶の需要が継続的に増加しています。この地域の消費者は、他の地域の消費者と比較して、自然な製品に多くの支出をしているので、この需要は、主に北米や欧州の先進地域で増加している。グミ、ゼリー、ソフトジェルなどの新しいタイプの栄養補助食品は市場に導入され、その採用が徐々に増えており、形状、サイズ、フレーバー、濃度など、無数に用意されています。これらの栄養補助食品のほとんどは毎日摂取することを意図しており、したがって、これらの品種は、それらが消費するために楽しいと認識されている場合、消費者がこれらの栄養補助食品を毎日持っていることを可能にします。
栄養補助食品の世界市場は、タイプ、形態、販売チャネル、および地域に基づいてセグメント化されています。タイプ別では、機能性飲料、機能性食品、栄養補助食品に二分されます。形状により、市場はカプセルおよび錠剤、液体、粉末、その他に区分されます。販売チャネルでは、ハイパーマーケット/スーパーマーケット、専門店、薬局、オンラインチャネルで調査しています。また、栄養補助食品の世界市場は、北米、ヨーロッパ、アジア太平洋地域、LAMEAで調査されています。
栄養補助食品市場の分析のためにプロファイルされた主要な選手の一部アーチャーダニエルズミッドランドカンパニー、BASF SE、カーギル社、ダノン、デュポン社、ゼネラルミルズ社、Koninklijke DSM N.V. 、ネスレ社、ペプシコ社、および株式会社ヤクルト本社、株式会社ヤクルト本社、株式会社ヤクルト本社。
ニュートラシューティカルズ関連市場セグメント
タイプ別
- 機能性飲料
- 機能性食品
- 健康補助食品
形態別
- カプセル・錠剤
- 液体
- 粉体
- その他
販売チャネル別
- ハイパーマーケット/スーパーマーケット
- 専門店
- 薬局
- オンラインチャネル
地域別
- 北アメリカ
o 米国
o カナダ
o メキシコ
- 欧州
o 英国
o ドイツ
o イタリア
o フランス
o スペイン
o その他の欧州地域
- アジア・パシフィック
o 中国
o 日本
o インド
o オーストラリア
o 韓国
o その他のアジア太平洋地域
- ラメア
o ブラジル
o アルゼンチン
o サウジアラビア
o アラブ首長国連邦
o 南アフリカ
o その他のLAMEA地域
主な市場関係者
- アーチャー・ダニエルズ・ミッドランド社
- BASF SE
- カーギル社
- ダノン
- デュポン株式会社
- ゼネラル・ミルズ社
- Koninklijke DSM N.V.
- ネスレS.A.
- ペプシコ・インク
- 株式会社ヤクルト本社

ページTOPに戻る

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors
2.1.2.Top investment pockets

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis

3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Threat of substitution
3.2.4.Threat of new entrants
3.2.5.Intensity of competitive rivalry

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Increase in demand for functional food in developing nations
3.3.1.2.Rise in consumption of sports and energy drinks.
3.3.1.3.Increase in purchasing power and changes in lifestyle and food habits.
3.3.1.4.Increasing demand for nutraceuticals to supplement regular diet

3.3.2.Restraints

3.3.2.1.Counterfeit and low quality products affecting the market.
3.3.2.2.Challenges related to manufacturing technology and processing.

3.3.3.Opportunities

3.3.3.1.Greater demands for herbal nutraceutical products can help the market grow.
3.3.3.2.New format of intakes of nutraceuticals

3.4.Covid-19 analysis

3.4.1.Overview:
3.4.2.Impact on food and beverage sector:
3.4.3.Impact on nutraceuticals market:

3.5.Supply chain analysis
3.6.Consumer survey analysis

CHAPTER 4:NUTRACEUTICALS MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by Type

4.2.Functional beverages

4.2.1.Key market trends, growth factors, and opportunities

4.2.1.1.Energy and Sports Drinks-
4.2.1.2.Functional Juices –
4.2.1.3.Others

4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Functional food

4.3.1.Key market trends, growth factors, and opportunities

4.3.1.1.Probiotics-
4.3.1.2.Minerals-
4.3.1.3.Proteins & Amino Acids-
4.3.1.4.Prebiotics, & Dietary Fibers-
4.3.1.5.Vitamins-
4.3.1.6.Others-

4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Dietary supplements

4.4.1.Key market trends, growth factors, and opportunities

4.4.1.1.Vitamins-
4.4.1.2.Botanicals-
4.4.1.3.Minerals-
4.4.1.4.Proteins & Amino Acids-
4.4.1.5.Fibers & Specialty Carbohydrates-
4.4.1.6.Omega Fatty Acids-
4.4.1.7.Others-

4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:NUTRACEUTICALS MARKET, BY FORM

5.1.Overview

5.1.1.Market size and forecast, by Form

5.2.Capsule and tablets

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Liquid

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Powder

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

5.5.Others

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country

CHAPTER 6:NUTRACEUTICALS MARKET, BY SALES CHANNEL

6.1.Overview

6.1.1.Market size and forecast, by Sales channel

6.2.Hypermarket/Supermarket

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Specialty stores

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Pharmacy

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

6.5.Online channels

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market analysis, by country

CHAPTER 7:NUTRACEUTICALS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by Type
7.2.3.Market size and forecast, by Form
7.2.4.Market size and forecast, by Sales channel
7.2.5.Market analysis, by Country

7.2.5.1.U.S.

7.2.5.1.1.Market size and forecast, by Type
7.2.5.1.2.Market size and forecast, by Form
7.2.5.1.3.Market size and forecast, by Sales channel

7.2.5.2.Canada

7.2.5.2.1.Market size and forecast, by Type
7.2.5.2.2.Market size and forecast, by Form
7.2.5.2.3.Market size and forecast, by Sales channel

7.2.5.3.Mexico

7.2.5.3.1.Market size and forecast, by Type
7.2.5.3.2.Market size and forecast, by Form
7.2.5.3.3.Market size and forecast, by Sales channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by Type
7.3.3.Market size and forecast, by Form
7.3.4.Market size and forecast, by Sales channel
7.3.5.Market analysis, by Country

7.3.5.1.UK

7.3.5.1.1.Market size and forecast, by Type
7.3.5.1.2.Market size and forecast, by Form
7.3.5.1.3.Market size and forecast, by Sales channel

7.3.5.2.Germany

7.3.5.2.1.Market size and forecast, by Type
7.3.5.2.2.Market size and forecast, by Form
7.3.5.2.3.Market size and forecast, by Sales channel

7.3.5.3.Italy

7.3.5.3.1.Market size and forecast, by Type
7.3.5.3.2.Market size and forecast, by Form
7.3.5.3.3.Market size and forecast, by Sales channel

7.3.5.4.France

7.3.5.4.1.Market size and forecast, by Type
7.3.5.4.2.Market size and forecast, by Form
7.3.5.4.3.Market size and forecast, by Sales channel

7.3.5.5.Spain

7.3.5.5.1.Market size and forecast, by Type
7.3.5.5.2.Market size and forecast, by Form
7.3.5.5.3.Market size and forecast, by Sales channel

7.3.5.6.Rest of Europe

7.3.5.6.1.Market size and forecast, by Type
7.3.5.6.2.Market size and forecast, by Form
7.3.5.6.3.Market size and forecast, by Sales channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by Type
7.4.3.Market size and forecast, by Form
7.4.4.Market size and forecast, by Sales channel
7.4.5.Market analysis, by country

7.4.5.1.China

7.4.5.1.1.Market size and forecast, by Type
7.4.5.1.2.Market size and forecast, by Form
7.4.5.1.3.Market size and forecast, by Sales channel

7.4.5.2.Japan

7.4.5.2.1.Market size and forecast, by Type
7.4.5.2.2.Market size and forecast, by Form
7.4.5.2.3.Market size and forecast, by Sales channel

7.4.5.3.India

7.4.5.3.1.Market size and forecast, by Type
7.4.5.3.2.Market size and forecast, by Form
7.4.5.3.3.Market size and forecast, by Sales channel

7.4.5.4.Australia

7.4.5.4.1.Market size and forecast, by Type
7.4.5.4.2.Market size and forecast, by Form
7.4.5.4.3.Market size and forecast, by Sales channel

7.4.5.5.South Korea

7.4.5.5.1.Market size and forecast, by Type
7.4.5.5.2.Market size and forecast, by Form
7.4.5.5.3.Market size and forecast, by Sales channel

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Market size and forecast, by Type
7.4.5.6.2.Market size and forecast, by Form
7.4.5.6.3.Market size and forecast, by Sales channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by Type
7.5.3.Market size and forecast, by Form
7.5.4.Market size and forecast, by Sales channel
7.5.5.Market analysis, by country

7.5.5.1.Brazil

7.5.5.1.1.Market size and forecast, by Type
7.5.5.1.2.Market size and forecast, by Form
7.5.5.1.3.Market size and forecast, by Sales channel

7.5.5.2.Argentina

7.5.5.2.1.Market size and forecast, by Type
7.5.5.2.2.Market size and forecast, by Form
7.5.5.2.3.Market size and forecast, by Sales channel

7.5.5.3.Saudi Arabia

7.5.5.3.1.Market size and forecast, by Type
7.5.5.3.2.Market size and forecast, by Form
7.5.5.3.3.Market size and forecast, by Sales channel

7.5.5.4.United Arab Emirates

7.5.5.4.1.Market size and forecast, by Type
7.5.5.4.2.Market size and forecast, by Form
7.5.5.4.3.Market size and forecast, by Sales channel

7.5.5.5.South Africa

7.5.5.5.1.Market size and forecast, by Type
7.5.5.5.2.Market size and forecast, by Form
7.5.5.5.3.Market size and forecast, by Sales channel

7.5.5.6.Rest of LAMEA

7.5.5.6.1.Market size and forecast, by Type
7.5.5.6.2.Market size and forecast, by Form
7.5.5.6.3.Market size and forecast, by Sales channel

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Product mapping
8.5.Top winning strategies
8.6.Key developments

8.6.1.Acquisition
8.6.2.Business Expansion
8.6.3.Joint Venture
8.6.4.Partnership
8.6.5.Product Launch

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILES

9.1.ARCHER DANIELS MIDLAND COMPANY

9.1.1.Company overview
9.1.2.Key executive
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.R&D expenditure
9.1.7.Business performance
9.1.8.Key strategic moves and developments

9.2.BASF SE

9.2.1.Company overview
9.2.2.Key Executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business performance
9.2.7.Key strategic moves and developments

9.3.CARGILL, INC.

9.3.1.Company overview
9.3.2.Key executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business performance
9.3.7.Key strategic moves and developments

9.4.DANONE

9.4.1.Company overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business performance
9.4.7.Key strategic moves and developments

9.5.DUPONT DE NEMOURS, INC.

9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.R&D Expenditure
9.5.7.Business performance

9.6.GENERAL MILLS INC.

9.6.1.Company overview
9.6.2.Key executives
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.R&D expenditure
9.6.7.Business performance
9.6.8.Key strategic moves and developments

9.7.KONINKLIJKE DSM N.V.

9.7.1.Company overview
9.7.2.Key executive
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio
9.7.6.R&D expenditure (Continued and discontinued operations)
9.7.7.Business performance (Continued and discontinued operations)

9.8.NESTLE S.A.

9.8.1.Company overview
9.8.2.Key Executives
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.R&D Expenditure
9.8.7.Business performance
9.8.8.Key strategic moves and developments

9.9.PEPSICO, INC.

9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio
9.9.6.R&D Expenditure
9.9.7.Business performance
9.9.8.Key strategic moves and developments

9.10.YAKULT HONSHA CO., LTD.

9.10.1.Company overview
9.10.2.Key Executives
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.R&D Expenditure
9.10.7.Business performance
9.10.8.Key strategic moves and developments

List of Tables

LIST OF TABLES

TABLE 01.NUTRACEUTICALS MARKET, BY TYPE, 2020–2030 ($ MILLION)
TABLE 02.FUNCTIONAL BEVERAGES NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 03.FUNCTIONAL FOOD NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 04.DIETARY SUPPLEMENTS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 05.NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 06.CAPSULE AND TABLETS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 07.LIQUID NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 08.POWDER NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 09.OTHERS NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 10.NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 11.NUTRACEUTICALS MARKET SALES VIA HYPERMARKET/SUPERMARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 12.NUTRACEUTICALS MARKET SALES VIA SPECIALTY STORES, BY REGION, 2020–2030 ($ MILLION)
TABLE 13.NUTRACEUTICALS MARKET SALES VIA PHARMACY, BY REGION, 2020–2030 ($ MILLION)
TABLE 14.NUTRACEUTICALS MARKET SALES VIA ONLINE CHANNELS, BY REGION, 2020–2030 ($ MILLION)
TABLE 15.NUTRACEUTICALS MARKET, BY REGION, 2020–2030 ($ MILLION)
TABLE 16.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 17.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 18.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 19.NORTH AMERICA NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 20.U.S. NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 21.U.S. NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 22.U.S. NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 23.CANADA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 24.CANADA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 25.CANADA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 26.MEXICO NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 27.MEXICO NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 28.MEXICO NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 29.EUROPE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 30.EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 31.EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 32.EUROPE NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 33.UK NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 34.UK NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 35.UK NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 36.GERMANY NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 37.GERMANY NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 38.GERMANY NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 39.ITALY NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 40.ITALY NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 41.ITALY NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 42.FRANCE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 43.FRANCE NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 44.FRANCE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 45.SPAIN NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 46.SPAIN NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 47.SPAIN NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 48.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 49.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 50.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 51.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 52.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 53.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 54.ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 55.CHINA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 56.CHINA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 57.CHINA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 58.JAPAN NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 59.JAPAN NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 60.JAPAN NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 61.INDIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 62.INDIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 63.INDIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 64.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 65.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 66.AUSTRALIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 67.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 68.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 69.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 70.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 71.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 72.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 73.LAMEA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 74.LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 75.LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 76.LAMEA NUTRACEUTICALS MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 77.BRAZIL NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 78.BRAZIL NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 79.BRAZIL NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 80.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 81.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 82.ARGENTINA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 83.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 84.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 85.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 86.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 87.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 88.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 89.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 90.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 91.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 92.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY TYPE, 2020–2030 ($ MILLION)
TABLE 93.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY FORM, 2020–2030 ($ MILLION)
TABLE 94.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, BY SALES CHANNEL, 2020–2030 ($ MILLION)
TABLE 95.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 96.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 97.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 98.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 99.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 100.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 101.BASF SE: KEY EXECUTIVES
TABLE 102.BASF SE: COMPANY SNAPSHOT
TABLE 103.BASF SE: OPERATING SEGMENTS
TABLE 104.BASF SE: PRODUCT PORTFOLIO
TABLE 105.BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 106.CARGILL, INC.: KEY EXECUTIVES
TABLE 107.CARGILL, INC.: COMPANY SNAPSHOT
TABLE 108.CARGILL, INC.: OPERATING SEGMENTS
TABLE 109.CARGILL, INC..: PRODUCT PORTFOLIO
TABLE 110.CARGILL, INC.: NET SALES, 2020-2021 ($MILLION)
TABLE 111.DANONE: KEY EXECUTIVES
TABLE 112.DANONE: COMPANY SNAPSHOT
TABLE 113.DANONE: OPERATING SEGMENTS
TABLE 114.DANONE: PRODUCT PORTFOLIO
TABLE 115.DANONE: NET SALES, 2018–2020 ($MILLION)
TABLE 116.DUPONT DE NEMOURS, INC.: KEY EXECUTIVES
TABLE 117.DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT
TABLE 118.DUPONT DE NEMOURS, INC.: OPERATING SEGMENTS
TABLE 119.DUPONT DE NEMOURS, INC.: PRODUCT PORTFOLIO
TABLE 120.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 121.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 122.GENERAL MILLS INC.: KEY EXECUTIVES
TABLE 123.GENERAL MILLS INC.: COMPANY SNAPSHOT
TABLE 124.GENERAL MILLS INC.: OPERATING SEGMENTS
TABLE 125.GENERAL MILLS INC.: PRODUCT PORTFOLIO
TABLE 126.GENERAL MILLS INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 127.GENERAL MILLS INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 128.KONINKLIJKE DSM N.V.: KEY EXECUTIVE
TABLE 129.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 130.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
TABLE 131.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 132.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 133.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)
TABLE 134.NESTLE S.A.: KEY EXECUTIVES
TABLE 135.NESTLE S.A.: COMPANY SNAPSHOT
TABLE 136.NESTLE S.A.: OPERATING SEGMENTS
TABLE 137.NESTLE S.A.: PRODUCT PORTFOLIO
TABLE 138.NESTLE S.A.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 139.NESTLE S.A.: NET SALES, 2018–2020 ($MILLION)
TABLE 140.PEPSICO, INC.: KEY EXECUTIVES
TABLE 141.PEPSICO, INC.: COMPANY SNAPSHOT
TABLE 142.PEPSICO, INC.: OPERATING SEGMENTS
TABLE 143.PEPSICO, INC.: PRODUCT PORTFOLIO
TABLE 144.PEPSICO, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 145.PEPSICO, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 146.YAKULT HONSHA CO., LTD.: KEY EXECUTIVES
TABLE 147.YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
TABLE 148.YAKULT HONSHA CO., LTD.: OPERATING SEGMENTS
TABLE 149.YAKULT HONSHA CO., LTD.: PRODUCT PORTFOLIO
TABLE 150.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 151.YAKULT HONSHA CO., LTD.: NET SALES, 2018–2020 ($MILLION)

List of Figures

LIST OF FIGURES

FIGURE 01.KEY MARKET SEGMENTS
FIGURE 02.EXECUTIVE SUMMARY
FIGURE 03.TOP IMPACTING FACTORS
FIGURE 04.TOP INVESTMENT POCKETS
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.LOW THREAT OF SUBSTITUTION
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 10.NUTRACEUTICALS MARKET, BY TYPE, 2020 (%)
FIGURE 11.COMPARATIVE VALUE SHARE ANALYSIS OF FUNCTIONAL BEVERAGES NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 12.COMPARATIVE VALUE SHARE ANALYSIS OF FUNCTIONAL FOOD NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE VALUE SHARE ANALYSIS OF DIETARY SUPPLEMENTS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.NUTRACEUTICALS MARKET, BY FORM, 2020 (%)
FIGURE 15.COMPARATIVE VALUE SHARE ANALYSIS OF CAPSULE AND TABLETS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE VALUE SHARE ANALYSIS OF LIQUID NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE VALUE SHARE ANALYSIS OF POWDER NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.COMPARATIVE VALUE SHARE ANALYSIS OF OTHERS NUTRACEUTICALS MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.NUTRACEUTICALS MARKET, BY SALES CHANNEL, 2020 (%)
FIGURE 20.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA HYPERMARKET/SUPERMARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA SPECIALTY STORES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 22.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA PHARMACY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 23.COMPARATIVE VALUE SHARE ANALYSIS OF NUTRACEUTICALS SALES VIA ONLINE CHANNELS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.NUTRACEUTICALS MARKET, BY REGION 2020 (%)
FIGURE 25.U.S. NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 26.CANADA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 27.MEXICO NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 28.UK NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 29.GERMANY NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 30.ITALY NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 31.FRANCE NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 32.SPAIN NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 33.REST OF EUROPE NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 34.CHINA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 35.JAPAN NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 36.INDIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 37.AUSTRALIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 38.SOUTH KOREA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 39.REST OF ASIA-PACIFIC NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 40.BRAZIL NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 41.ARGENTINA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 42.SAUDI ARABIA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 43.UNITED ARAB EMIRATES NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 44.SOUTH AFRICA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 45.REST OF LAMEA NUTRACEUTICALS MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 46.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 49.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 50.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 51.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 52.PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 53.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 54.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 55.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 58.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 59.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 60.CARGILL, INC..: NET SALES, 2020-2021 ($MILLION)
FIGURE 61.DANONE: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.DANONE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 63.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 64.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 65.DUPONT DE NEMOURS, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66.DUPONT DE NEMOURS, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 67.GENERAL MILLS INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 68.GENERAL MILLS INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 69.GENERAL MILLS INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 70.GENERAL MILLS INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 71.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 72.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 73.KONINKLIJKE DSM N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 74.KONINKLIJKE DSM N.V.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 75.NESTLE S.A.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 76.NESTLE S.A.: NET SALES, 2018–2020 ($MILLION)
FIGURE 77.NESTLE S.A.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 78.NESTLE S.A.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 79.PEPSICO, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 80.PEPSICO, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 81.PEPSICO, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 82.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 83.YAKULT HONSHA CO., LTD.: NET SALES, 2018–2020 ($MILLION)
FIGURE 84.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 85.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY REGION, 2020 (%)

ページTOPに戻る

Table of Contents

Summary

Nutraceuticals are health products that are labelled under foods but are also utilized for medicinal purposes. They are also called bioceuticals as they are made from food materials and extracts. Nutraceuticals s are used for treatment and prevention of diseases and as supplements to maintain and improve health and wellbeing, prevent chronic diseases, delay aging, support the structure or function of the body, and increase life expectancy. There are various types of Nutraceuticals products available in the market that are used for a variety of applications. As these products are considered to be food supplements or additives, they are unregulated in many countries across the world.
Consumer across the world are looking for customizable food, beverages, and dietary solutions that will help them more aggressively meet their own unique nutrition and personal health goals. Active and health-conscious consumers have shifted their preference toward natural alternatives for sugar-based drinks that are rich in carbohydrates and unhealthy chemicals. Functional beverages consist of specific nutrients and supplements, which enhance athletic performance and metabolism. Appropriate nutrition is an essential prerequisite for effective improvement of athletic performance, conditioning, recovery from fatigue after exercise, and rapid recovery of injury. In addition, it helps in diabetes management. Changes in lifestyle of consumers has been one of the major factors that has contributed toward the growing popularity of functional food in developing economies. In Asia-Pacific countries, surge in per capita income has led to changing food habits of customers. Rise in aspiration and penchant for luxury lifestyle has led to manifold increase in market size and overall demand.
Demand for Nutraceuticals products is growing rapidly. The main reason for this increase is the increasing awareness regarding the health and wellness benefits due to the consumption of Nutraceuticals supplements. Furthermore, adoption of severe lifestyles due to work pressure and greater consumption of fast food is propelling consumers to search for supplements that can help in maintaining wellbeing of the consumers. Increasing consumption of unhealthy food is leading to diseases like high cholesterol, obesity, bone degradation, and heart related diseases. More consumers are reporting increase in fitness activities like visiting gyms and athletic centers to maintain health, and are coupling these activities with Nutraceuticals s in order to gain maximum results.
Many consumers are avoiding chemical ingredients in their food, health food, functional food, proteins, and Nutraceuticals products. Hence, demand for naturally sourced ingredients and herbal canned tomatoes is increasing continuously. This demand is mainly increasing in developed regions of North America and Europe as consumers in this region are spending more on natural products compared to consumers in other regions. Newer types of Nutraceuticals s in the forms of gummies, jellies, and soft gels are being introduced in the market and their adoption is gradually increasing, they are available in a myriad of shapes, sizes, flavors and concentrations. Most of these Nutraceuticals s are intended for daily consumption, and hence these varieties make it possible for consumers to have these Nutraceuticals daily if they are perceived to be fun to consume.
The global Nutraceuticals market is segmented on the basis of type, form, sales channel, and region. Based on type, the global market is bifurcated into functional beverage, functional food, and dietary supplements. By form the market is segmented into capsules and tablets, liquid, powder, others. Based on sales channel the global market is studied across hypermarkets/supermarkets, specialty stores, pharmacies, and online channels. The global Nutraceuticals market is also studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players profiled for in the Nutraceuticals market analysis Archer Daniels Midland Company, BASF SE, Cargill, Inc., Danone, DuPont de Nemours, Inc., General Mills Inc., Koninklijke DSM N.V., Nestle S.A., PepsiCo, Inc., and Yakult Honsha Co., Ltd.
Nutraceuticals Market Segments
By Type
• Functional Beverage
• Functional Food
• Dietary Supplement
By Form
• Capsule and Tablets
• Liquid
• Powder
• Others
By Sales Channel
• Hypermarket/Supermarket
• Specialty Stores
• Pharmacy
• Online Channels
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o Italy
o France
o Spain
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Argentina
o Saudi Arabia
o United Arab Emirates
o South Africa
o Rest of LAMEA
Key Market Players
• Archer Daniels Midland Company
• BASF SE
• Cargill, Inc.
• Danone
• DuPont de Nemours, Inc.
• General Mills Inc,
• Koninklijke DSM N.V.
• Nestle S.A.
• PepsiCo, Inc.
• Yakult Honsha Co., Ltd.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（dietary）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（dietary）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?